Conventional knockout of the
microsomal triglyceride transfer protein large subunit (lMTP) gene is embryonic lethal in the homozygous state in mice. We have produced a conditional lMTP knockout mouse by inserting loxP sequences flanking exons 5 and 6 by gene targeting. Homozygous floxed mice were born live with normal plasma
lipids.
Intravenous injection of an adenovirus harboring
Cre recombinase (AdCre1) produced deletion of exons 5 and 6 and disappearance of lMTP
mRNA and immunoreactive
protein in a liver-specific manner. There was also disappearance of plasma
apolipoprotein (
apo) B-100 and marked reduction in
apoB-48 levels. Wild-type mice showed no response, and heterozygous mice, an intermediate response, to AdCre1. Wild-type mice doubled their plasma
cholesterol level following a high
cholesterol diet. This
hypercholesterolemia was abolished in AdCre1-treated lMTP-/- mice, the result of a complete absence of very low/intermediate/
low density lipoproteins and a slight reduction in
high density lipoprotein. Heterozygous mice showed an intermediate
lipoprotein phenotype. The rate of accumulation of plasma
triglyceride following Triton WR1339 treatment in lMTP-/- mice was <10% that in wild-type animals, indicating a failure of
triglyceride-rich
lipoprotein production. Pulse-chase experiments using hepatocytes isolated from wild-type and lMTP-/- mice revealed a failure of
apoB secretion in lMTP-/- animals. Therefore, the liver-specific inactivation of the lMTP gene completely abrogates
apoB-100 and very low/intermediate/
low density lipoprotein production. These conditional knockout mice are a useful in vivo model for studying the role of MTP in
apoB biosynthesis and the biogenesis of
apoB-containing
lipoproteins.